Avinza Side Effects

Serious Adverse Side Effects

Avinza | Morphine Sulfate Extended-Release has many serious and possibly fatal adverse side effects associated with it, such as:

Cardiovascular side effects such as cardiac arrest, disorders of the cardiovascular system, hypotension, shock, and fainting
Immunological side effects such as anaphylaxis, a life-threatening allergic reaction
Musculoskeletal side effects such as muscle twitching
Neurological side effects such as intracranial pressure
Respiratory side effects such as shortness of breath and respiratory depression

Common Adverse Side Effects

More common and comparatively less severe adverse side effects associated with Avinza | Morphine Sulfate Extended-Release are:

Cardiovascular side effects such as peripheral edema, or swelling of the tissues
Dermatological side effects such as itching and sweating
Gastrointestinal side effects such as abdominal pain, constipation, diarrhea, loss of appetite, nausea, vomiting, and dry mouth
Hepatic side effects such as abnormal liver function
Neurological side effects such as loss of strength, dizziness, headache, insomnia, lightheadedness, burning and prickling of the skin, and drowsiness
Ophthalmic side effects such as lazy eye
Psychiatric side effects such as anxiety and depression
Renal side effects such as urinary retention
Other side effects such as hiccup and fevers

Warnings & Recalls for Avinza

Black Box Warning

There is a “black box” warning associated with Avinza that warns patients that this drug is indicated for once daily use. Furthermore, Avinza | Morphine Sulfate Extended-Release shouldn’t be crushed, split of chewed due to the absorption of a potentially lethal dose of morphine. Avinza | Morphine Sulfate Extended-Release shouldn’t be used concurrently with alcohol.

Contraindications

The contraindications of Avinza | Morphine Sulfate Extended-Release are:

Severe or acute asthma
Compromised blood pressure
Severe hypercarbia
Hypersensitivity to morphine
Paralytic ileus

Who Should Not Take This Drug

The following warnings, precautions and preexisting conditions hinder a patient’s ability to take Avinza | Morphine Sulfate Extended-Release:

Those who are susceptible to abuse or recreational drugs
In patients with severe renal or hepatic impairments
Addison’s disease
Opioid intolerant patients
Hypothyroidism
Prostatic hypertrophy
Urethral stricture patients
Elderly or debilitated patients

Avinza Treatment and Use

Avinza | Morphine Sulfate Extended-Release is a drug that is prescribed to treat moderate to severe pain. The necessity of this drug is only for patients who require medication that is powerful enough to relieve moderate to severe pain on an extended basis. The drug classification of Avinza | Morphine Sulfate Extended-Release is that of an opiate narcotic analgesic and works by incrementally changing the way the body reacts to pain.

The official FDA-labeled indications for this drug are for:

Pain from heart attacks
Use as an anesthetic
Obstetric pain
Moderate to severe chronic pain
Postoperative pain
Use as a premedication before an anesthetic procedure
Acute pulmonary edema

Non-FDA labeled indications for this drug are:

As an analgesic in intensive care unit
Pain in the eye

How does Avinza work?

Morphine sulfate is known as a pure opioid agonist and in the central nervous system, promotes analgesic qualities by changing the way the brain responds to pain. This drug also decreases gastric, biliary, and pancreatic secretion.

Dosage

Avinza | Morphine Sulfate Extended-Release is made available in the following dosages:

30mg
45mg
60mg
75mg
90mg
120mg

Other Names for Avinza

Brand Names

Avinza

MS Contin

MSIR

Kadian

Oramorph

Roxanol

Kapanol

Generic Name

Morphine Sulfate Extended-Release Capsules